| About the author: |
Bukach O. P., Fediv A. I., Sidorchuk L. P. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Тo assess polymorphic variants of eNOS gene (rs 2070744) in patients with RA depending on the degree of activity of acute-phase indicators. Material and methods. During the study involved 60 patients with RA who gave written informed consent to participate in the study and 20 healthy individuals representative by age and sex. Molecular genetic study of the polymorphism of T-786C gene еNOS conducted in a public institution "Reference center" The Ministry of health Ukraine (Kiev) by polymerase chain reaction (PCR). Results. We have analyzed the influence of the polymorphism T-786C in the promoter of the gene of endothelial nitric oxide synthase (eNOS) on the course of rheumatoid arthritis (RA), which was accompanied by an increase in blood of acute-phase indices of inflammation, joint disorders, connective tissue 1.67-102,28 times (p≤0,049-0,001), which, however, has no clear dependence on polymorphic variants of eNOS gene (rs 2070744), except for C-reactive protein, which is higher in carriers of the unfavorable СС-genotype by 32.13% (p=0,035). Also among homozygous carriers of the mutant C-allele are relatively more common entity with the content of IgG antibodies to cyclic citrullinemia peptide (A-CCP) in blood plasma higher than normal values" by 18.29% (p=0.04), with more severe RA (III degree of activity) – 14.28% (p=0.001) and high level functional failure of the joints (3 degree) by 22.12%. According to epidemiological risk analysis favorable TT genotype associated with lower activity of RA (I stage ) [OR=0,21; p=0.007], lower radiographic stage (I stage) and to a lesser extent to functional failure of the joints (I stage) [OR=0,10; p=0,021]. |
| Tags |
rheumatoid arthritis, polymorphic variants of the gene T-786C eNOS, acute phase indicators |
| Bibliography |
- Golovach I. Yu. Naukovo obgruntovani rekomendatsiyi EULAR (2010) schodo menedzhmentu sertsevo-sudinnogo riziku v patsientiv iz revmatoyidnim artritom i zapalnimi artritami / I. Yu. Golovach// Ukr. revmatol. zh. – 2011. – No.44 (2). – S. 5-13.
- Kovalenko V. M. Regionalni osoblivosti rivnya zdorovia narodu Ukrayini/ V. M. Kovalenko, V. M. Kornatskiy // – Analitichno-statistichniy posibnik. – Kiyiv. – 2011. – 165 s.
- Kovalenko V. M. Suchasni pidhodi do klinichnoyi ta laboratorno-instrumentalnoyi diagnostiki rannogo revmatoyidnogo artritu / V. M. Kovalenko, D. G. Rekalov [ta in.] // Ukrayinskiy medichniy almanah. – 2011. – No.4 (14). – S. 88-96.
- Sidorchuk L. P. Farmakogenetika arterialnoyi gipertenziyi / L.P. Sidorchuk // – Chernivtsi: BDMU, - 2010. – 532 s.
- Solomenchuk T. M. Kardiovaskulyarniy rizik u patsientiv z revmatoyidnim artritom: osoblivosti stratifikatsiyi ta osnovni napryami profilaktiki / T. M. Solomenchuk, O. S. Ivanik, O. V. Sinenkiy // Zdoroviya Ukrayini. – 2015. – No.2 (39). S. 62-63.
- Cattaruzza M. Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells. / M. Cattaruzza, W. Slodowski, M. Stojakovic [et al.] // J. Biol. Chem. – 2003. – Vol. 278. – P. 37874–37880.
- Doshi A. A. A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium. / A. A. Doshi, M.T. Ziolo, H. Wang [et al.] // J. Card. Fail. – 2010. – Vol. 16(4). – P. 314–319.
- Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. / M.G. Colombo, U. Paradossi, M.G. Andreassi [et al.] // Clin. Chem. – 2003. – Vol. 49. – P. 389–395.
- Ezzidi I. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. / I. Ezzidi, N. Mtiraoui, M.B. Mohamed [et al.] // J. Diabetes Complications. – 2008. – Vol. 22(5). – P.331–338.
- Farook Thameem. Endothelial Nitric Oxide Synthase (eNOS) gene polymorphisms and their association with Type 2 diabetes related traits in Mexican Americans / Farook Thameem, Sobha Puppala, Nedal H. Arar // Diab Vasc Dis Res. Author manuscript. -2008.- Vol. 5(2). –109 p.
- Hyndman M. E. The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension. / M. E. Hyndman, H. G. Parsons, S. Verma [et al.] // Hypertension. – 2002. – Vol. 39(4). – P. 919–922.
- Lembo G. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. / G. Lembo, N. De Luca, C. Battagli [et al.] // Stroke. – 2001. – Vol. 32(3). – P. 735–740.
- Melchers I. The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis. / I. Melchers, S. Blaschke, M. Hecker [et al.] // Arthritis Rheum. – 2006. – Vol. 54 (10). – P. 3144-3151.
- Rossi G. P. The T–786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. / G. P. Rossi, M. Cesari, M. Zanchetta [et al.] // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 930–937.
- Salimi S. Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease. / S. Salimi, M. Firoozrai, H. Zand [et al.] // Ann. Saudi Med. – 2010. – Vol. 30(1). – P. 33-37.
- Sydorchuk L. Humoral markers of endothelial dysfunction and systemic inflammatory response in patients with acute myocardial infarction depending on genes polymorphism of ACE (I/D) and eNOS (894G> T) / L. Sydorchuk, Y. Ursuliak, A. Sydorchuk [et al.] // The Pharma Innovation J. – 2015. – Vol. 3 (4). – P. 1-10.
- Zhang W. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis / W. Zhang, M. Doherty, G. Peat [et al.] // Ann. Rheum. Dis. – 2010. - Vol. 69. – P. 483–489.
|
| Publication of the article |
«World of Medicine and Biology» №1(59), 2017 year, 023-027 pages, index UDK 616.72-002.77-071-036:575.113.1 |
